Discovery of an AKT Degrader with Prolonged Inhibition ofDownstream Signaling
I. You, E. Erickson, K. Donovan, N. Eleuteri, E. S. Fischer, N. S. Gray, A. Toker
This study develops INY-03-041, a pan-AKT degrader that shows prolonged inhibition of AKT and downstream signaling effects compared to traditional inhibitors.
bioRxiv · Nov 20, 2019Cancer Biology